Cox TM - Search Results

1

RIPK3 as a potential therapeutic target for Gaucher's disease.

Vitner EB, Salomon R, Farfel-Becker T, Meshcheriakova A, Ali M, Klein AD, Platt FM, Cox TM, Futerman AH. Vitner EB, et al. Among authors: cox tm. Nat Med. 2014 Feb;20(2):204-8. doi: 10.1038/nm.3449. Epub 2014 Jan 19. Nat Med. 2014. PMID: 24441827

2

Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

Cox T, Lachmann R, Hollak C, Aerts J, van Weely S, Hrebícek M, Platt F, Butters T, Dwek R, Moyses C, Gow I, Elstein D, Zimran A. Cox T, et al. Lancet. 2000 Apr 29;355(9214):1481-5. doi: 10.1016/S0140-6736(00)02161-9. Lancet. 2000. PMID: 10801168 Clinical Trial.

3

Treatment with miglustat reverses the lipid-trafficking defect in Niemann-Pick disease type C.

Lachmann RH, te Vruchte D, Lloyd-Evans E, Reinkensmeier G, Sillence DJ, Fernandez-Guillen L, Dwek RA, Butters TD, Cox TM, Platt FM. Lachmann RH, et al. Among authors: cox tm. Neurobiol Dis. 2004 Aug;16(3):654-8. doi: 10.1016/j.nbd.2004.05.002. Neurobiol Dis. 2004. PMID: 15262277

4

Critical role of iron in the pathogenesis of the murine gangliosidoses.

Jeyakumar M, Williams I, Smith D, Cox TM, Platt FM. Jeyakumar M, et al. Among authors: cox tm. Neurobiol Dis. 2009 Jun;34(3):406-16. doi: 10.1016/j.nbd.2009.01.015. Neurobiol Dis. 2009. PMID: 19449457

5

Inhibition of UDP-glucosylceramide synthase in mice prevents Gaucher disease-associated B-cell malignancy.

Pavlova EV, Archer J, Wang S, Dekker N, Aerts JM, Karlsson S, Cox TM. Pavlova EV, et al. Among authors: cox tm. J Pathol. 2015 Jan;235(1):113-24. doi: 10.1002/path.4452. J Pathol. 2015. PMID: 25256118

6

Emerging therapeutic targets for Gaucher disease.

Vitner EB, Vardi A, Cox TM, Futerman AH. Vitner EB, et al. Among authors: cox tm. Expert Opin Ther Targets. 2015 Mar;19(3):321-34. doi: 10.1517/14728222.2014.981530. Epub 2014 Nov 21. Expert Opin Ther Targets. 2015. PMID: 25416676 Review.

7

Gaucher disease and comorbidities: B-cell malignancy and parkinsonism.

Cox TM, Rosenbloom BE, Barker RA. Cox TM, et al. Am J Hematol. 2015 Jul;90 Suppl 1:S25-8. doi: 10.1002/ajh.24057. Am J Hematol. 2015. PMID: 26096744 Free article. Review.

8

Identification of Modifier Genes in a Mouse Model of Gaucher Disease.

Klein AD, Ferreira NS, Ben-Dor S, Duan J, Hardy J, Cox TM, Merrill AH Jr, Futerman AH. Klein AD, et al. Among authors: cox tm. Cell Rep. 2016 Sep 6;16(10):2546-2553. doi: 10.1016/j.celrep.2016.07.085. Epub 2016 Aug 25. Cell Rep. 2016. PMID: 27568557 Free article.

9

Reduced cerebral vascularization in experimental neuronopathic Gaucher disease.

Smith NJ, Fuller M, Saville JT, Cox TM. Smith NJ, et al. Among authors: cox tm. J Pathol. 2018 Jan;244(1):120-128. doi: 10.1002/path.4992. J Pathol. 2018. PMID: 28981147

10

In-depth phenotyping for clinical stratification of Gaucher disease.

D'Amore S, Page K, Donald A, Taiyari K, Tom B, Deegan P, Tan CY, Poole K, Jones SA, Mehta A, Hughes D, Sharma R, Lachmann RH, Chakrapani A, Geberhiwot T, Santra S, Banka S, Cox TM; MRC GAUCHERITE Consortium. D'Amore S, et al. Among authors: cox tm. Orphanet J Rare Dis. 2021 Oct 14;16(1):431. doi: 10.1186/s13023-021-02034-6. Orphanet J Rare Dis. 2021. PMID: 34649574 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

272 results

Search Page